68% of patients showed clinical improvement using Gilead's Remdesivir in 'compassionate use'

CNBC's Meg Tirrell reports the latest data on how Gilead's Remdesivir was used for 'compassionate use' on 53 patients and what doctors have found. The update was published in the New England Journal of Medicine.
Mon, Apr 13 202011:04 AM EDT